News Center



News Center

News

Viwit Pharmaceuticals obtained the Drug Production License C

Viwit Pharmaceuticals obtained the Drug Production License C

Congratulations to Viwit Pharmaceuticals that Viwit obtained the Drug Production License C for solid preparations and injections on July 28th, 2023. Meaning, that Viwit’s production lines for solid preparations and injections own the qualification on contracted manufacturing.

30

2023

/

10

Viwit Pharmaceuticals’BFS Technology

Viwit Pharmaceuticals’BFS Technology

Viwit’s sterile blow-fill-seal (BFS) eye drops manufacturing facility is established in 2021. The BFS production line fulfills the need for an advanced aseptic manufacturing process using the state of the art Rommelag 434 BFS system. Pharmaceutical grade low-density polyethylene (PE) is used to ensure product quality and prevent leachable and leakage. A strip of 15 doses attached to each other can be created and filled within a few seconds. Every single BFS ampule is detected for leakage to ensure the integrity of the dose.

18

2023

/

10

Meeting Viwit Pharmaceuticals at CPHI Barcelona

Meeting Viwit Pharmaceuticals at CPHI Barcelona

Viwit Pharmaceuticals will be participating in CPHI Barcelona 2023 in Oct. 24th~26th, 2023 at Fira Barcelona Gran Via, Spain. Welcome to visit our booth 7D30 or contact us to learn more about our full portfolio of products, services, and solutions. We look forward to seeing you soon!

18

2023

/

09

SST Corporation and Viwit Pharmaceuticals Establish Strategic Collaboration

SST Corporation and Viwit Pharmaceuticals Establish Strategic Collaboration

Having become an officially qualified API/CMC supplier to SST Corporation, Viwit and SST have established a strategic collaboration aiming to promote small molecule pharmaceutical contract development and manufacturing organization (CDMO) services in North America.

11

2023

/

08

Viwit Pharmaceutical Invites You to Meet at CPHI North America

Viwit Pharmaceutical Invites You to Meet at CPHI North America

Viwit Pharmaceuticals will be participating in the CPHI North America conference this year from April 25- 27，2023 at Pennsylvania Convention Center, in Philadelphia. Welcome to stop by our booth # 1114 and explore how our CDMO services and solutions would benefit your drug development and manufacturing pipeline. We are looking forward to meeting and collaborating with you in the heart of the US pharma Industry!

01

2023

/

03

Viwit Pharmaceutical Is Now Officially GMP Certified by South Korean MFDS

Viwit Pharmaceutical Is Now Officially GMP Certified by South Korean MFDS

Shandong, February 13, 2023 -- Viwit Pharmaceutical, an innovation-driven global company providing CDMO services to pharmaceutical and biotech industries, successfully passed the GMP inspection and approved by the South Korean regulatory agency, the Ministry of Food and Drug Safety (MFDS).

27

2023

/

02

Viwit Pharmaceutical Co., Ltd. participated in CPHI Worldwide 2022 held in Frankfurt Germany from November 1st to November 3rd.

Viwit Pharmaceutical Co., Ltd. participated in CPHI Worldwide 2022 held in Frankfurt Germany from November 1st to November 3rd.

As the world's largest pharmaceutical industry exhibition, CPHI has been successfully held for 30 years. It displays the entire pharmaceutical supply chain, from API, P-MEC to FDF. It becomes the largest annual gathering of pharmaceutical professionals all over the world. Viwit met old friends and new business partners at CPHI. We displayed a wonderful enterprise image with our products and services, and promoted our international business through CPHI.

09

2022

/

11

Viwit participants in CPhI China 2019, booth: W2B28

Viwit participants in CPhI China 2019, booth: W2B28

CPhI China 2019 will be held at Shanghai New International Expo Center on June 18-20, 2019. Welcome to patronage of Viwit, booth number: W2B28. If you would like to make an appointment in advance, please email us at service@viwit.com.

18

2019

/

06

< 1234567 >

Search

Confirm
%{tishi_zhanwei}%